Tabriz University of Medical Sciences About    Newsletter    Contact Us    Create Account    Log in  
Advanced Pharmaceutical Bulletin
ISSN: 2228-5881      eISSN: 2251-7308  
Services
Export citation
EndNote
Reference Manager
BibTeX
Medlars
Refworks
Mendeley

Cite by
Google Scholar
PMC(0)


Article History
Submitted: 23 Nov 2014
Revised: 11 May 2015
Accepted: 14 May 2015
First published online: 31 Dec 2015

Article Access Statistics
Abstract Page Views: 400
PDF Downloads: 176
Full Text Views: 0

Adv Pharm Bull. 2015;5(5):629-636 doi: 10.15171/apb.2015.085
PMID:26793608        PMCID:PMC4708033

In Silico Analysis of HA2/Mx Chimera Peptide for Developing an Adjuvanted Vaccine to Induce Immune Responses Against Influenza Viruses

Original Research

Sina Soleimani 1,2, Omid Madadgar 1, Shahla Shahsavandi 2 * , Homayoon Mahravani 2, Mohsen Lotfi 2

1 Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
2 Razi Vaccine & Serum Research Institute, Karaj, Iran.



Abstract
Purpose: The direct transmission of avian influenza viruses to human and increasing drug resisted strains posing new threats for public health. Therefore, development of efficient vaccines is needed to generate protective and persistent immunity to the viruses. Methods: Three motifs of Mx protein sequence in human, mouse and poultry located in interferon induced (GTP ase) domain were candidate as biologic adjuvant for enhancing the immune responses against influenza virus. Chimera proteins composed with the conserved HA2 subunit of influenza virus and the Mx motifs named HA2/Mx were modeled and evaluated by in silico analysis includes bioinformatics algorithms in order to explore biological characteristics of these peptides. Results: Amongst the predicted models, HA2/Mx1 peptide showed the better results following protein structures prediction, antigenic epitopes determination and model quality evaluation. Comparative homology modeling was performed with Swiss Model and the model was validated using ProSA. Epitope predictions revealed the construct could induce both B and T cell epitopes that expect a high immune response. Conclusion: Taken together, these data indicate that the HA2/Mx1 chimera peptide can be potentiated for developing an adjuvant-fused influenza vaccine capable of stimulating effective immune response.





Comments
First name  
Last name  
Email address  
Comments  
Security code



This Article
PDF

Google Scholar
Articles by Soleimani S
Articles by Madadgar O
Articles by Shahsavandi S
Articles by Mahravani H
Articles by Lotfi M

PubMed
Articles by Soleimani S
Articles by Madadgar O
Articles by Shahsavandi S
Articles by Mahravani H
Articles by Lotfi M

Similar articles in PubMed

Share this article!

Press Manuscript Online. Powered by MAADRAYAN